William Blair and Amgen

Selected healthcare news for the capital firm - William Blair, and the company - Amgen. We have 72 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
3/5/2021 Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Neurocrine (NBIX) and Ovid Therapeutics (OVID) Analysts‚Ao Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Neurocrine (NBIX) and Ovid Therapeutics (OVID) Catie Powers - March 5, 2021, 4:35 PM EDT SHARE ON:Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen ( AMGN ), Neurocrine ( NBIX ) and Ovid Therapeutics ( OVID ).Amgen (AMGN)In a report issued on March 1, Matt Phipps from William Blair maintained a Hold rating ...
1/14/2021 Amgen Inc. to Post FY2021 Earnings of $17.10 Per Share, Cantor Fitzgerald Forecasts (NASDAQ:AMGN) - Ticker Report Ticker Report Amgen Inc. (NASDAQ:AMGN) ‚Ai Equities research analysts at Cantor Fitzgerald upped their FY2021 EPS estimates for Amgen in a research note issued on Wednesday, January 13th. Cantor Fitzgerald analyst A. Young now anticipates that ... rating in a research report on Tuesday, December 15th. Finally, William Blair reiterated a ‚Auhold‚Au rating on shares of Amgen in a report on Wednesday, September 23rd. Three analysts have rated the stock with ...
1/8/2021 Amgen (NASDAQ:AMGN) Rating Reiterated by Royal Bank of Canada Daily Political Fifth Third Bancorp (NASDAQ:FITB) Trading Up 9.6% Following Analyst Upgrade Amgen (NASDAQ:AMGN) Rating Reiterated by Royal Bank of Canada January 7th, 2021 - Comments Off on Amgen (NASDAQ:AMGN) Rating Reiterated by Royal Bank ... a buy rating in a report on Tuesday, December 15th. William Blair reaffirmed a hold rating on shares of Amgen in a report on Wednesday, September 23rd. UBS Group initiated coverage on shares of Amgen ...
1/6/2021 Amgen's (AMGN) ‚ÄúNeutral‚Äù Rating Reiterated at Royal Bank of Canada Mayfield Recorder Amgen‚Aos (AMGN) ‚AuNeutral‚Au Rating Reiterated at Royal Bank of Canada Posted by Frank Smitson on Jan 6th, 2021Amgen (NASDAQ:AMGN) ‚Aos stock had its ‚Auneutral‚Au rating reissued by research analysts at Royal Bank of Canada in a research report issued to clients and investors on Monday, Borsen Zeitung reports.Several other brokerages have also issued reports on AMGN. William Blair reaffirmed a ‚Auhold‚Au rating on ...
1/4/2021 Amgen (NASDAQ:AMGN) Upgraded at BidaskClub - Ticker Report Ticker Report BidaskClub upgraded shares of Amgen (NASDAQ:AMGN) from a strong sell rating to a sell rating in a research report sent to investors on Friday, BidAskClub reports.Several other analysts also recently commented on the ... a buy rating in a report on Tuesday, December 15th. William Blair reissued a hold rating on shares of Amgen in a report on Wednesday, September 23rd. Finally, Truist raised shares of Amgen from a ...
1/2/2021 Amgen (NASDAQ:AMGN) Given Neutral Rating at Royal Bank of Canada Amgen (NASDAQ:AMGN) Given Neutral Rating at Royal Bank of Canada Posted by Cynthia Vaughn on Jan 2nd, 2021Royal Bank of Canada reissued their neutral rating on shares of Amgen (NASDAQ:AMGN) in a ... a sell rating in a report on Thursday, October 8th. William Blair reissued a hold rating on shares of Amgen in a report on Wednesday, September 23rd. Finally, Bank of America lowered their price target ...
1/1/2021 Amgen (NASDAQ:AMGN) Earns “Neutral” Rating from Royal Bank of Canada ... Plummet 4% as Russia and OPEC Consider Easing CapsRoyal Bank of Canada restated their neutral rating on shares of Amgen (NASDAQ:AMGN) in a research report sent to investors on Tuesday morning, Borsen Zeitung ... overweight rating in a research report on Wednesday, December 16th. William Blair restated a hold rating on shares of Amgen in a report on Wednesday, September 23rd. Finally, Truist upgraded shares of Amgen from a ...
1/1/2021 Amgen (NASDAQ:AMGN) Rating Increased to Sell at BidaskClub Amgen (NASDAQ:AMGN) Rating Increased to Sell at BidaskClub Posted by Sam Norman on Jan 1st, 2021Amgen (NASDAQ:AMGN) was upgraded by research analysts at BidaskClub from a ‚Austrong sell‚Au rating to a ... stock in a research report on Thursday, October 29th. Finally, William Blair reissued a ‚Auhold‚Au rating on shares of Amgen in a report on Wednesday, September 23rd. Three research analysts have rated the stock ...
1/1/2021 Amgen Inc. to Post FY2023 Earnings of $18.52 Per Share, Oppenheimer Forecasts (NASDAQ:AMGN) - Ticker Report Ticker Report Amgen Inc. (NASDAQ:AMGN) ‚Ai Equities researchers at Oppenheimer dropped their FY2023 EPS estimates for shares of Amgen in a note issued to investors on Sunday, December 27th. Oppenheimer analyst J. Olson now expects that ... rating in a research note on Wednesday, December 9th. Finally, William Blair restated a ‚Auhold‚Au rating on shares of Amgen in a research note on Wednesday, September 23rd. Three investment analysts have rated the ...
11/2/2020 Q4 2020 Earnings Estimate for Amgen Inc. Issued By Jefferies Financial Group (NASDAQ:AMGN) Amgen Inc. (NASDAQ:AMGN) – Equities researchers at Jefferies Financial Group cut their Q4 2020 earnings per share (EPS) estimates for Amgen in a report issued on Wednesday, October 28th. Jefferies Financial Group analyst M ... other research analysts have also recently weighed in on AMGN. William Blair reiterated a “hold” rating on shares of Amgen in a report on Wednesday, September 23rd. SunTrust Banks increased their target price on ...
11/2/2020 Amgen (NASDAQ:AMGN) PT Lowered to $304.00 at BMO Capital Markets Amgen (NASDAQ:AMGN) PT Lowered to $304.00 at BMO Capital Markets Posted by Dante Gardener Nov 2nd, 2020Amgen (NASDAQ:AMGN) had its price target lowered by BMO Capital Markets from $308.00 to $304.00 in ... line rating in a research report on Wednesday, July 29th. William Blair restated a hold rating on shares of Amgen in a report on Wednesday, September 23rd. Royal Bank of Canada reaffirmed a hold rating ...
11/2/2020 Amgen (NASDAQ:AMGN) PT Lowered to $265.00 Amgen (NASDAQ:AMGN) PT Lowered to $265.00 Posted by Caroline Horne Nov 2nd, 2020Amgen (NASDAQ:AMGN) had its price target reduced by Bank of America from $275.00 to $265.00 in a research note published on Thursday, Benzinga reports. They currently have a buy rating on the medical research company‚Aos stock.A number of other equities research analysts also recently weighed in on the company. William Blair reiterated a ...
11/2/2020 Amgen (NASDAQ:AMGN) PT Lowered to $304.00 at BMO Capital Markets | Daily Political Daily Political Amgen (NASDAQ:AMGN) had its price target lowered by BMO Capital Markets from $308.00 to $304.00 in a research report report published on Thursday, AnalystRatings.net reports. BMO Capital Markets currently has an outperform rating on ... line rating in a research report on Wednesday, July 29th. William Blair restated a hold rating on shares of Amgen in a report on Wednesday, September 23rd. Royal Bank of Canada reaffirmed a hold rating ...
6/2/2020 Amgen (AMGN) Receives a Hold from William Blair Amgen (AMGN) Receives a Hold from William Blair Brian Anderson - June 2, 2020, 7:24 AM EDT SHARE ON: In a report released yesterday, Matt Phipps from William Blair maintained a Hold rating on Amgen ( AMGN ). The company’s shares closed last Monday at $226.91. According to TipRanks.com , Phipps is a 4-star analyst with an average return of 13.1% and a 54.7% success rate. Phipps covers the Healthcare sector, focusing on ...
4/24/2020 Amgen, Inc. Forecasted to Post Q2 2020 Earnings of $4.02 Per Share (NASDAQ:AMGN) American Banking News Amgen, Inc. (NASDAQ:AMGN) – Stock analysts at William Blair decreased their Q2 2020 earnings per share estimates for shares of Amgen in a research note issued on Tuesday, April 21st. William Blair analyst M. Phipps now forecasts that the medical research company will earn $4.02 per share for the quarter, down from their prior estimate of $4.05. Get Amgen alerts: Other research analysts also recently issued research reports about the ...
4/23/2020 Amgen, Inc. Forecasted to Earn Q3 2020 Earnings of $3.79 Per Share (NASDAQ:AMGN) American Banking News Amgen, Inc. (NASDAQ:AMGN) – Equities researchers at William Blair lowered their Q3 2020 earnings per share estimates for shares of Amgen in a research report issued on Tuesday, April 21st. William Blair analyst M. Phipps now forecasts that the medical research company will earn $3.79 per share for the quarter, down from their prior estimate of $3.82. William Blair also issued estimates for Amgen’s Q4 2020 earnings at $3.29 EPS ...
12/4/2019 Amgen (NASDAQ:AMGN) Sets New 1-Year High at $236.00 | Daily Political Amgen, Inc. (NASDAQ:AMGN)’s share price hit a new 52-week high on Monday . The stock traded as high as $236.00 and last traded at $233.96, with a volume of 6987 shares traded. The stock $234.72.AMGN has been the subject of several recent analyst reports. Evercore ISI reissued a “hold” rating on shares of Amgen in a research note on Sunday, August 11th. William Blair reaffirmed a “hold ...
11/28/2019 William Blair Equities Analysts Raise Earnings Estimates for Amgen, Inc. (NASDAQ:AMGN) Amgen, Inc. (NASDAQ:AMGN) – Research analysts at William Blair boosted their Q1 2020 EPS estimates for Amgen in a research note issued to investors on Monday, November 25th. William Blair analyst M. Phipps now expects that the medical research company will post earnings of $3.79 per share for the quarter, up from their prior estimate of $3.78. William Blair currently has a “Hold” rating on the stock. William Blair also ...
11/28/2019 William Blair Analysts Boost Earnings Estimates for Amgen, Inc. (NASDAQ:AMGN) - WKRB News Amgen, Inc. (NASDAQ:AMGN) – Stock analysts at William Blair upped their FY2019 earnings per share (EPS) estimates for Amgen in a report issued on Monday, November 25th. William Blair analyst M. Phipps now expects that the medical research company will earn $14.59 per share for the year, up from their previous forecast of $14.43. William Blair currently has a “Hold” rating on the stock. William Blair also issued estimates for ...
11/27/2019 FY2019 EPS Estimates for Amgen, Inc. (NASDAQ:AMGN) Increased by Analyst FY2019 EPS Estimates for Amgen, Inc. (NASDAQ:AMGN) Increased by Analyst Posted by Cynthia Vaughn on Nov 27th, 2019 Amgen, Inc. (NASDAQ:AMGN) – William Blair upped their FY2019 EPS estimates for Amgen in a report released on Monday, November 25th. William Blair analyst M. Phipps now forecasts that the medical research company will earn $14.59 per share for the year, up from their prior forecast of $14.43. William Blair currently ...
11/27/2019 Q1 2020 Earnings Forecast for Amgen, Inc. (NASDAQ:AMGN) Issued By William Blair Amgen, Inc. (NASDAQ:AMGN) – Research analysts at William Blair boosted their Q1 2020 EPS estimates for Amgen in a research note issued to investors on Monday, November 25th. William Blair analyst M. Phipps now expects that the medical research company will post earnings of $3.79 per share for the quarter, up from their prior estimate of $3.78. William Blair currently has a “Hold” rating on the stock. William Blair also ...
11/26/2019 William Blair Weighs in on Amgen, Inc.’s FY2019 Earnings (NASDAQ:AMGN) - American Banking News Amgen, Inc. (NASDAQ:AMGN) – Stock analysts at William Blair lifted their FY2019 earnings estimates for Amgen in a report issued on Monday, November 25th. William Blair analyst M. Phipps now anticipates that the medical research company will earn $14.59 per share for the year, up from their prior forecast of $14.43. William Blair currently has a “Hold” rating on the stock. William Blair also issued estimates for Amgen’s Q4 2019 ...
11/19/2019 Amgen (NASDAQ:AMGN) PT Raised to $205.00 Amgen (NASDAQ:AMGN) PT Raised to $205.00 Posted by Sean Solarzano on Nov 19th, 2019 Amgen (NASDAQ:AMGN) had its price target upped by equities research analysts at Leerink Swann from $189.00 to $205.00 in ... Several other research analysts also recently issued reports on AMGN. William Blair reiterated a “hold” rating on shares of Amgen in a report on Friday, August 30th. Cantor Fitzgerald set a $230.00 price target on ...
11/12/2019 Amgen (NASDAQ:AMGN) Hits New 52-Week High at $221.38 Amgen, Inc. (NASDAQ:AMGN) shares hit a new 52-week high during mid-day trading on Monday . The stock traded as high as $221.38 and last traded at $220.70, with a volume of 1361027 shares ... 14th. They set an “outperform” rating on the stock. Finally, William Blair reissued a “hold” rating on shares of Amgen in a research report on Friday, August 30th. Ten research analysts have rated the stock ...
11/9/2019 FY2019 EPS Estimates for Amgen, Inc. Raised by William Blair (NASDAQ:AMGN) Amgen, Inc. (NASDAQ:AMGN) – Stock analysts at William Blair upped their FY2019 earnings per share (EPS) estimates for shares of Amgen in a report released on Wednesday, October 30th, according to Zacks Investment Research . William Blair analyst M. Phipps now anticipates that the medical research company will post earnings of $14.43 per share for the year, up from their previous estimate of $14.20. William Blair currently has a “Hold” rating ...